Noninvasix
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Houston, Texas, United StatesPhone Number
(409) 772-2965Website
www.noninvasix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Noninvasix
Noninvasix is pioneering a non-invasive solution for continuously measuring central venous saturation, which is crucial for assessing the severity of sepsis and septic shock. Their patented optoacoustic platform technology enables real-time monitoring, allowing clinicians to diagnose and tailor treatments for critically ill patients more effectively. The company aims to address the urgent need for improved sepsis detection and monitoring, ultimately enhancing patient care and reducing healthcare costs. Future applications may extend to various medical settings where tissue hypoxia is a concern.Explore more
Noninvasix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Noninvasix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Noninvasix has recently received funding, and reach out quickly before it becomes old news!
Noninvasix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Noninvasix is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Noninvasix
Product Launch: Get notified when Noninvasix launches new products
Website visits: Recent activity has been detected on your website
Click to see if Noninvasix had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Noninvasix has new funding data
Earning: See what the market has to say on Noninvasix recently announced quarterly report
Recommended Actions
Find VP level buyers at Noninvasix
Find 3 more new buyers
Compare Similar Companies to Noninvasix
Compare insights from companies similar to Noninvasix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Noninvasix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Noninvasix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Noninvasix.
Noninvasix Tech Stack
A closer look at the technologies used by Noninvasix
Noninvasix News & Media
Noninvasix Appoints David J. Giarracco as CEO
HOUSTON--(BUSINESS WIRE)--Noninvasix announced today that David J. Giarracco has been appointed the new CEO of the company. A veteran medical device executive with relevant critical care market experience, Giarracco will advance the commercialization of the only non-invasive patient monitoring device designed for earlier detection of life-threatening sepsis so it can be treated to improve patient outcomes. “Dave is the right leader at the right time for Noninvasix,” said Tom Luby, Ph.D., DirectAngelMD Investor Group Closes Second Round of Funding in Noninvasix
Neonatal monitoring company directly, accurately, and noninvasively measures brain oxygenation to lower incidents of mortality and morbidity. (PRWeb January 07, 2019) Read the full story at https://www.prweb.com/releases/angelmd_investor_group_closes_second_round_of_funding_in_noninvasix/prweb16018138.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Noninvasix
Sign Up For FreeTo access detailed company insights
Noninvasix is pioneering a non-invasive solution for continuously measuring central venous saturation, which is crucial for assessing the severity of sepsis and septic shock. Their patented optoacoustic platform technology enables real-time monitoring, allowing clinicians to diagnose and tailor treatments for critically ill patients more effectivel... Read More
